Literature DB >> 23615078

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis.

J Harenberg1, J Walenga, G Torri, O E Dahl, L Drouet, J Fareed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23615078     DOI： 10.1111/jth.12269

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

Review 1.  Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.

Authors:  Jacobus R B J Brouwers; Jeanine E Roeters van Lennep; Maarten J Beinema
Journal:  Br J Clin Pharmacol       Date:  2019-09-04       Impact factor: 4.335

2.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 3.  The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV).

Authors:  Davide Imberti; Marco Marietta; Hernan Polo Friz; Claudio Cimminiello
Journal:  Thromb J       Date:  2017-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.